Juvenile dermatomyositis: a tertiary center experience.

about

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody.

P2860

Q55311957-89B14F7F-E983-4C3D-9C09-4BDE765E7E92

P2860

Juvenile dermatomyositis: a tertiary center experience.

Item

http://www.wikidata.org/entity/Q39036962

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Juvenile dermatomyositis: a tertiary center experience.

@en

Juvenile dermatomyositis: a tertiary center experience.

@nl

type

Item

label

Juvenile dermatomyositis: a tertiary center experience.

@en

Juvenile dermatomyositis: a tertiary center experience.

@nl

prefLabel

Juvenile dermatomyositis: a tertiary center experience.

@en

Juvenile dermatomyositis: a tertiary center experience.

@nl

P1476

Juvenile dermatomyositis: a tertiary center experience.

@en

P2093

Amra Adrovic

http://www.w3.org/2001/XMLSchema#string

Kenan Barut

http://www.w3.org/2001/XMLSchema#string

Pinar Ozge Avar Aydin

http://www.w3.org/2001/XMLSchema#string

Sezgin Sahin

http://www.w3.org/2001/XMLSchema#string

P2860

Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies

Current Perspectives on Imaging for Systemic Lupus Erythematosus, Systemic Sclerosis, and Dermatomyositis/Polymyositis.

Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM).

Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.

Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

P304

361-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-016-3530-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ozgur Kasapcopur

P577

2017-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28058540

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

Juvenile dermatomyositis: a tertiary center experience.

about

P2860

P2860

Juvenile dermatomyositis: a tertiary center experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921